TBH I had discounted NanoDX 6 months ago, but recently had my faith restored that it may actually be happening. I had settled on a 1M share investment on AbioMed, the LifeScan CGM , a strong looking order book and a company that was approaching cash positive. However, based on NanoDX had increased to closer to 2M ( bugger ! ), have now reduced my position to closer to the original holding, which I am comfortable with for a business that is turning the corner WITHOUT NanoDX. Having said that, the quarterly better be a ripper !
IMO. GLTAH
SE1 Price at posting:
2.4¢ Sentiment: Buy Disclosure: Held
